GB0329146D0 - Vaccine - Google Patents

Vaccine

Info

Publication number
GB0329146D0
GB0329146D0 GBGB0329146.5A GB0329146A GB0329146D0 GB 0329146 D0 GB0329146 D0 GB 0329146D0 GB 0329146 A GB0329146 A GB 0329146A GB 0329146 D0 GB0329146 D0 GB 0329146D0
Authority
GB
United Kingdom
Prior art keywords
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0329146.5A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Ludwig Institute for Cancer Research Ltd
Ludwig Cancer Research
Original Assignee
GlaxoSmithKline Biologicals SA
Ludwig Institute for Cancer Research Ltd
Ludwig Cancer Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline Biologicals SA, Ludwig Institute for Cancer Research Ltd, Ludwig Cancer Research filed Critical GlaxoSmithKline Biologicals SA
Priority to GBGB0329146.5A priority Critical patent/GB0329146D0/en
Publication of GB0329146D0 publication Critical patent/GB0329146D0/en
Priority to PCT/EP2004/014379 priority patent/WO2005058349A2/en
Priority to US10/582,810 priority patent/US20070048261A1/en
Priority to EP04803988A priority patent/EP1694358A2/en
Priority to JP2006544346A priority patent/JP2007513992A/ja
Priority to CA002548512A priority patent/CA2548512A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB0329146.5A 2003-12-16 2003-12-16 Vaccine Ceased GB0329146D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB0329146.5A GB0329146D0 (en) 2003-12-16 2003-12-16 Vaccine
PCT/EP2004/014379 WO2005058349A2 (en) 2003-12-16 2004-12-14 Vaccine comprising il-12 or il-23 for treatment of autoimmune diseases
US10/582,810 US20070048261A1 (en) 2003-12-16 2004-12-14 Vaccine comprising il-12 or il-23 for treatment of autoimmune diseases
EP04803988A EP1694358A2 (en) 2003-12-16 2004-12-14 Vaccine comprising il-12 or il-23 for treatment of autoimmune diseases
JP2006544346A JP2007513992A (ja) 2003-12-16 2004-12-14 自己免疫疾患の治療用のｉｌ−１２又はｉｌ−２３を含むワクチン
CA002548512A CA2548512A1 (en) 2003-12-16 2004-12-14 Vaccine comprising il-12 or il-23 for treatment of autoimmune diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0329146.5A GB0329146D0 (en) 2003-12-16 2003-12-16 Vaccine

Publications (1)

Publication Number Publication Date
GB0329146D0 true GB0329146D0 (en) 2004-01-21

Family

ID=30471161

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0329146.5A Ceased GB0329146D0 (en) 2003-12-16 2003-12-16 Vaccine

Country Status (6)

Country Link
US (1) US20070048261A1 (enExample)
EP (1) EP1694358A2 (enExample)
JP (1) JP2007513992A (enExample)
CA (1) CA2548512A1 (enExample)
GB (1) GB0329146D0 (enExample)
WO (1) WO2005058349A2 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005108425A1 (en) * 2004-05-10 2005-11-17 Cytos Biotechnology Ag Il-23 p19 antigen array and uses thereof
EP2982679A1 (en) 2005-10-12 2016-02-10 Idera Pharmaceuticals, Inc. Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response
US8377898B2 (en) * 2006-10-12 2013-02-19 Idera Pharmaceuticals, Inc. Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
TWI426918B (zh) 2007-02-12 2014-02-21 Merck Sharp & Dohme Ｉｌ-２３拮抗劑於治療感染之用途
JP2012505221A (ja) 2008-10-06 2012-03-01 イデラ ファーマシューティカルズ インコーポレイテッド 高コレステロール血症および高脂血症ならびにそれらに関連する疾患の予防および処置におけるトル様受容体の阻害剤の使用
WO2011033493A1 (en) 2009-09-21 2011-03-24 Conservatoire National des Arts et Métiers Carrier conjugates of il-23-peptides and their induced antibodies
CN103415302A (zh) 2010-11-19 2013-11-27 艾德拉药物股份有限公司 调控基于toll-样受体的免疫应答的免疫调节寡核苷酸(iro)化合物
CA2898237A1 (en) * 2013-03-15 2014-09-25 The Trustees Of The University Of Pennsylvania Vaccines having an antigen and interleukin-23 as an adjuvant
EP2998322A4 (en) * 2013-05-14 2016-12-14 Shanghai Hycharm Inc EPITOPOXULENT FOR LOW IMMUNOGENOUS PROTEIN AND METHOD OF PREPARATION AND USE THEREOF
US10406218B2 (en) * 2014-04-09 2019-09-10 La Jolla Institute For Allergy And Immunology Specific and unique T cell responses and molecular signatures for the treatment and diagnosis of Mycobacterium tuberculosis
EP3302536A1 (en) * 2015-06-03 2018-04-11 Affiris AG Il-23-p19 vaccines
GB201522329D0 (en) * 2015-12-17 2016-02-03 Glaxosmithkline Biolog S A And Inst Nat De La Sante Et De La Rech Medicale Inserm And Université Pie Use of adjuvants for the prevention and/or treatment of autoimmune diseases
SG11201809381XA (en) 2016-05-18 2018-12-28 Modernatx Inc Polynucleotides encoding interleukin-12 (il12) and uses thereof
JP7285220B2 (ja) 2017-05-18 2023-06-01 モデルナティエックス インコーポレイテッド 連結したインターロイキン－１２（ｉｌ１２）ポリペプチドをコードするポリヌクレオチドを含む脂質ナノ粒子
JP2020534352A (ja) * 2017-09-07 2020-11-26 キュー バイオファーマ，インコーポレーテッド コンジュゲーション部位を有するｔ細胞調節多量体ポリペプチド及びその使用方法
GB201907413D0 (en) * 2019-05-24 2019-07-10 Univ Helsinki Viral vector
KR20230042053A (ko) 2020-07-22 2023-03-27 (주)쓰리에이치바이오 면역 치료제용 펩타이드

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA95960B (en) * 1994-03-14 1995-10-10 Genetics Inst Use of interleukin-12 antagonists in the treatment of autoimmune diseases
DK0832107T3 (da) * 1995-06-07 2001-11-19 Dlo Inst Voor Dierhouderij En Forbedret peptid, immunogen sammensætning og vaccine eller medicinsk præparat, fremgangsmåde til immunisering af dyr mod hormonet LHRH samt analoge af LHRH-tandempeptid-gentagelsespeptidet og deres andvendelse som vaccine
AU1407997A (en) * 1995-12-01 1997-06-19 Beth Israel Hospital Il-12 p40 subunit fusion polypeptides and uses thereof
GB9712347D0 (en) * 1997-06-14 1997-08-13 Smithkline Beecham Biolog Vaccine
PT1049717E (pt) * 1998-01-23 2007-05-31 Hoffmann La Roche Anticorpos contra a il-12 humana.
CA2328504A1 (en) * 1998-06-15 1999-12-23 Altarex Corp. Immunotherapeutic composition and method for the treatment of prostate cancer
US6902734B2 (en) * 2000-08-07 2005-06-07 Centocor, Inc. Anti-IL-12 antibodies and compositions thereof
US20030082179A1 (en) * 2001-07-03 2003-05-01 Hutchison James Scott Parathyroid hormone antibodies and related methods

Also Published As

Publication number Publication date
CA2548512A1 (en) 2005-06-30
EP1694358A2 (en) 2006-08-30
WO2005058349A3 (en) 2005-08-25
WO2005058349A2 (en) 2005-06-30
JP2007513992A (ja) 2007-05-31
US20070048261A1 (en) 2007-03-01

Similar Documents

Publication Publication Date Title
GB0226722D0 (en) Vaccine
GB0329146D0 (en) Vaccine
GB0225788D0 (en) Vaccine
GB0225786D0 (en) Vaccine
GB0323840D0 (en) Vaccines
GB0228715D0 (en) Vaccine
GB0209878D0 (en) Vaccine
IL173921A0 (en) Vaccine
GB0305794D0 (en) Vaccine
PL376534A1 (pl) Szczepionka
GB0330079D0 (en) Vaccine
GB0305793D0 (en) Vaccine
GB0321614D0 (en) Vaccines
GB0304634D0 (en) Vaccines
AU2003237701A8 (en) Vaccines
GB0206595D0 (en) Vaccine
IL156434A0 (en) Vaccine
GB0330007D0 (en) Vaccines
GB0226179D0 (en) Vaccine
GB0223355D0 (en) Vaccine
GB0329827D0 (en) Vaccine
GB0327885D0 (en) Vaccine
GB0326757D0 (en) Vaccine
GB0305028D0 (en) Vaccine
GB0300397D0 (en) Vaccines

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)